Migraine and stroke perspectives for stroke physicians

Stroke

Volumn 43, Issue 12, 2012, Pages 3421-3426

  Kurth, Tobias ^a,b,c   Diener, Hans Christoph ^d  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Migraine; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; C REACTIVE PROTEIN; CLOPIDOGREL; ERGOT ALKALOID; ORAL CONTRACEPTIVE AGENT; PROTHROMBIN; TRIPTAN DERIVATIVE; VON WILLEBRAND FACTOR;

ARTERY DISSECTION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CADASIL; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; ENDOTHELIAL DYSFUNCTION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HEART MYXOMA; HEART RIGHT LEFT SHUNT; HEREDITY; HUMAN; HYPERCOAGULABILITY; ICD-9; INFLAMMATION; MELAS SYNDROME; MIGRAINE; MIGRAINE AURA; MIGRAINE WITH AURA; MIGRAINOUS STROKE; MOYAMOYA DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATENT FORAMEN OVALE; PATHOPHYSIOLOGY; PERINATAL PERIOD; PHYSICIAN; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SNEDDON SYNDROME; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE; WHITE MATTER LESION;

HUMANS; MIGRAINE DISORDERS; NEUROLOGY; PREVALENCE; RISK FACTORS; STROKE;

EID: 84870913700     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.656603     Document Type: Review

References (56)

1. Collaborative Group for the Study of Stroke in Young Women. Oral contraceptives and stroke in young women: associated risk factors. JAMA. 1975;231:718-722.
2. Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. The World Health Organisation collaborative study of cardiovascular disease and steroid hormone contraception. BMJ. 1999;318:13-18.
3. Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E, et al. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk In Communities Study. Neurology. 2005;64:1573-1577.
4. MacClellan LR, Giles WH, Cole J, Wozniak MA, Stern B, Mtichell B, et al. Probable migraine with visual aura and risk of ischemic stroke: the Stroke Prevention in Young Women Study. Stroke. 2007;38:2438-2445.
5. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ. 2005;330:63.
6. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009;339:b3914.
7. Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med. 2010;123:612-624.
8. Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med. 2011;17:439-447.
9. Kurth T, Chabriat H, Bousser MG. Migraine and stroke: a complex association with clinical implications. Lancet Neurol. 2012;11:92-100.
10. Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med. 2005;118(suppl 1):3S-10S.
11. Rist PM, Diener HC, Kurth T, Schurks M. Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis. Cephalalgia. 2011;31:886-896.
12. Kurth T, Schurks M, Logroscino G, Buring JE. Migraine frequency and risk of cardiovascular disease in women. Neurology. 2009;73:581-588.
13. Donaghy M, Chang CL, Poulter N. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry. 2002;73:747-750.
14. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology. 2005;64:614-620.
15. Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, et al. Migraine and cardiovascular disease: a population-based study. Neurology. 2010;74:628-635.
16. Milhaud D, Bogousslavsky J, van Melle G, Liot P. Ischemic stroke and active migraine. Neurology. 2001;57:1805-1811.
17. Kurth T, Schurks M, Logroscino G, Gaziano JM, Buring JE. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ. 2008;337:a636.
18. Pezzini A, Grassi M, Lodigiani C, Patella R, Gandolfo C, Casoni F, et al. Predictors of migraine subtypes in young adults with ischemic stroke: the Italian project on stroke in young adults. Stroke. 2011;42:17-21.
19. Rist PM, Buring JE, Kase CS, Schurks M, Kurth T. Migraine and functional outcome from ischemic cerebral events in women. Circulation. 2010;122:2551-2557.
20. Kurth T, Kase CS, Schurks M, Tzourio C, Buring JE. Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ. 2010;341:c3659.
21. Bushnell CD, Jamison M, James AH. Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. BMJ. 2009;338:b664.
22. Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol. 2004;61:1366-1368.
23. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291:427-434.
24. Scher AI, Gudmundsson LS, Sigurdsson S, Ghambaryan A, Aspelund T, Eiriksdottir G, et al. Migraine headache in middle age and late-life brain infarcts. JAMA. 2009;301:2563-2570.
25. Kurth T, Mohamed S, Maillard P, Zhu YC, Chabriat H, Mazoyer B, et al. Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. BMJ. 2011;342:c7357.
26. Reinhard M, Schork J, Allignol A, Weiller C, Kaube H. Cerebellar and cerebral autoregulation in migraine. Stroke. 2012;43:987-993.
27. Wammes-van der Heijden EA, Rahimtoola H, Leufkens HG, Tijssen CC, Egberts AC. Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology. 2006;67:1128-1134.
28. Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology. 2004;62:563-568.
29. Sochurkova D, Moreau T, Lemesle M, Menassa M, Giroud M, Dumas R. Migraine history and migraine-induced stroke in the Dijon stroke registry. Neuroepidemiology. 1999;18:85-91.
30. Olesen J, Bousser M-G, Diener H, Dodick D, First M, Goadsby P, et al. The International Classification of Headache Disorders: II Edition. Cephalalgia. 2004;24(suppl 1):9-160.
31. Vroomen PC, Buddingh MK, Luijckx GJ, De Keyser J. The incidence of stroke mimics among stroke department admissions in relation to age group. J Stroke Cerebrovasc Dis. 2008;17:418-422.
32. Olesen J, Friberg L, Olsen TS, Andersen AR, Lassen NA, Hansen PE, et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain. 1993;116:187-202.
33. Tentschert S, Wimmer R, Greisenegger S, Lang W, Lalouschek W. Headache at stroke onset in 2196 patients with ischemic stroke or transient ischemic attack. Stroke. 2005;36:e1-e3.
34. Debette S, Markus HS. The genetics of cervical artery dissection: a systematic review. Stroke. 2009;40:e459-466.
35. Tzourio C, El Amrani M, Robert L, Alperovitch A. Serum elastase activity is elevated in migraine. Ann Neurol. 2000;47:648-651.
36. Duyff RF, Snijders CJ, Vanneste JA. Spontaneous bilateral internal carotid artery dissection and migraine: a potential diagnostic delay. Headache. 1997;37:109-112.
37. Diener HC, Kurth T, Dodick D. Patent foramen ovale, stroke, and cardiovascular disease in migraine. Curr Opin Neurol. 2007;20:310-319.
38. Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117:1397-1404.
39. Rundek T, Elkind MS, Di Tullio MR, Carrera E, Jin Z, Sacco RL, et al. Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation. 2008;118:1419-1424.
40. Garg P, Servoss SJ, Wu JC, Bajwa ZH, Selim MH, Dineen A, et al. Lack of association between migraine headache and patent foramen ovale: results of a case-control study. Circulation. 2010;121:1406-1412.
41. Nozari A, Dilekoz E, Sukhotinsky I, Stein T, Eikermann-Haerter K, Liu C, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol. 2010;67:221-229.
42. Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology. 2007;68:1563-1570.
43. Tietjen GE, Herial NA, White L, Utley C, Kosmyna JM, Khuder SA. Migraine and biomarkers of endothelial activation in young women. Stroke. 2009;40:2977-2982.
44. Tietjen GE, Al-Qasmi MM, Athanas K, Dafer RM, Khuder SA. Increased von Willebrand factor in migraine. Neurology. 2001;57:334-336.
45. Schurks M, Buring JE, Kurth T. Migraine features, associated symptoms and triggers: a principal component analysis in the Women's Health Study. Cephalalgia. 2011;31:861-869.
46. Anttila V, Stefansson H, Kallela M, Todt U, Terwindt GM, Calafato MS, et al. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet. 2010;42:869-873.
47. Chasman DI, Schurks M, Anttila V, de Vries B, Schminke U, Launer LJ, et al. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet. 2011;43:695-698.
48. Pezzini A, Grassi M, Del Zotto E, Giossi A, Monastero R, Dalla Volta G, et al. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke. 2007;38:3145-3151.
49. Schurks M, Zee RY, Buring JE, Kurth T. Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology. 2008;71:505-513.
50. Kurth T, Ridker PM, Buring JE. Migraine and biomarkers of cardiovascular disease in women. Cephalalgia. 2008;28:49-56.
51. Schurks M, Buring JE, Ridker PM, Chasman DI, Kurth T. Genetic determinants of cardiovascular events among women with migraine: a genome-wide association study. PLoS One. 2011;e22106.
52. Wijman CA, Wolf PA, Kase CS, Kelly-Hayes M, Beiser AS. Migrainous visual accompaniments are not rare in late life: the Framingham Study. Stroke. 1998;29:1539-1543.
53. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Risk indicators for development of headache during dipyridamole treatment after cerebral ischaemia of arterial origin. J Neurol Neurosurg Psychiatry. 2009;80:437-439.
54. Buring JE, Peto R, Hennekens CH. Low-dose aspirin for migraine prophylaxis. JAMA. 1990;264:1711-1713.
55. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart. 2005;91:1173-1175.
56. Schrader H, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ. 2001;322:19-22.